Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France

Travel Medicine and Infectious Disease - Tập 35 - Trang 101738 - 2020
Matthieu Million1,2, Jean-Christophe Lagier1,2, Philippe Gautret1,3, Philippe Colson1,2, Pierre-Edouard Fournier4,3, Sophie Amrane1,2, Marie Hocquart4, Morgane Mailhe1, Vera Esteves-Vieira4, Barbara Doudier1, Camille Aubry4, Florian Correard5,6, Audrey Giraud-Gatineau1,3,7,8, Yanis Roussel1,2, Cyril Berenger4,3, Nadim Cassir1,2, Piseth Seng1,2, Christine Zandotti4, Catherine Dhiver1, Isabelle Ravaux4
1IHU-Méditerranée Infection, Marseille, France
2Aix Marseille Univ., IRD, AP-HM, MEPHI, Marseille, France
3Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France
4IHU Méditerranée Infection, Marseille, France
5Aix Marseille Univ., Laboratoire de Pharmacie Clinique, Marseille, France
6AP-HM, hôpital Timone, service Pharmacie, Marseille, France
7Centre d'Epidémiologie et de Santé Publique des Armées (CESPA), Marseille, France
8AP-HM, Marseille, France

Tài liệu tham khảo

Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3 Yao, 2020, In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Clin Infect Dis, 5801998 Liu, 2020, Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro, Cell Discov, 6, 16, 10.1038/s41421-020-0156-0 Weston, 2020, Broad anti-coronaviral activity of FDA approved drugs against 1 SARS-CoV-2 in vitro and SARS-CoV in vivo, bioRxiv Touret, 2020, In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication, bioRxiv Andreani, 2020, In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect, Microb Pathog, 104228, 10.1016/j.micpath.2020.104228 Chen, 2020, Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial, medRxiv Tang, 2020, Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial, medRxiv Ashraf, 2020, COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes, medRxiv Chen, 2020, A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19), J Zhejiang Unniv (Med Sci), 49 Mahevas, 2020, No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection and requiring oxygen: results of a study using routinely collected data to emulate a target trial, medRxiv Magagnoli, 2020, Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19, medRxiv Gautret, 2020, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int J Antimicrob Agents, 105949, 10.1016/j.ijantimicag.2020.105949 Gautret, 2020, Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: an observational study, Trav Med Infect Dis, 101663, 10.1016/j.tmaid.2020.101663 Retallack, 2016, Zika virus cell tropism in the developing human brain and inhibition by azithromycin, Proc Natl Acad Sci U S A, 113, 14408, 10.1073/pnas.1618029113 Madrid, 2015, Evaluation of Ebola virus inhibitors for drug repurposing, ACS Infect Dis, 1, 317, 10.1021/acsinfecdis.5b00030 Bosseboeuf, 2018, Azithromycin inhibits the replication of Zika virus, J Antivir Antiretrovir, 10, 6, 10.4172/1948-5964.1000173 Sermo, 2020 Amrane, 2020, Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: a respiratory virus snapshot, Trav Med Infect Dis, 101632, 10.1016/j.tmaid.2020.101632 Liao, 2020, Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China, Intensive Care Med, 46, 357, 10.1007/s00134-020-05954-2 Armstrong, 2017, Simultaneous UHPLC-UV analysis of hydroxychloroquine, minocycline and doxycycline from serum samples for the therapeutic drug monitoring of Q fever and Whipple's disease, J Chromatogr B Analyt Technol Biomed Life Sci, 1060, 166, 10.1016/j.jchromb.2017.06.011 Lagier, 2014, Treatment of classic Whipple's disease: from in vitro results to clinical outcome, J Antimicrob Chemother, 69, 219, 10.1093/jac/dkt310 La Scola, 2020, Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards, Eur J Clin Microbiol Infect Dis, 10.1007/s10096-020-03913-9 Hadfield, 2018, Nextstrain: real-time tracking of pathogen evolution, Bioinformatics, 34, 4121, 10.1093/bioinformatics/bty407 Lane, 2020, Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study, medRxiv Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention, J Am Med Assoc, 10.1001/jama.2020.2648 Dong, 2020, Discovering drugs to treat coronavirus disease 2019 (COVID-19), Drug Discov Ther, 14, 58, 10.5582/ddt.2020.01012 Sung-sun, 2020, Physicians work out treatment guidelines for coronavirus, Korea Biomedical Review